PITTSBURGH, July 2, 2024 /PRNewswire/ — Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Division of the U.S. Department of Justice (“DOJ”) has advised that it no longer considers Mylan, and its former President, Rajiv Malik, a subject of its antitrust investigation in the…

CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S. FDA for the treatment of patients with multiple myeloma who have had at least one prior line of therapy RARITAN, N.J., July 2, 2024 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) announced today positive…

Merging Doctor Visits, Telemedicine, and AI for Comprehensive eHealth VANCOUVER, BC, July 2, 2024 /PRNewswire/ – UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) (“UniDoc,” or the “Company”), an innovator in the eHealth sector, proudly announces an update on the H3 Health Cube, a…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.